サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426354

肝炎診断検査の世界市場レポート 2024

Hepatitis Diagnostic Tests Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
肝炎診断検査の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

肝炎診断検査の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.9%の年間複合成長率（CAGR）で58億5,000万米ドルに成長すると予想されます。 肝炎診断検査の予測期間で予想される成長は、いくつかの主要な要因によるものと考えられます。これらには、世界の健康安全保障、人口増加と都市化の動向、目的に合わせた検査戦略の実施、肝炎撲滅プログラムの重視、世界全体のヘルスケア支出の増加などに対する懸念の高まりが含まれます。予測期間中に予想される主な動向には、検査技術、特に分子診断分野での進歩、異なる肝炎ウイルスに対するマルチプレックス検査の開発、診断とモニタリングの改善のためのデジタルヘルスソリューションの統合、ヘルスケア部門における戦略的提携やパートナーシップの増加が含まれる。これらの動向は、今後一定期間における肝炎診断検査の成長と進化の予測に総合的に寄与しています。

輸血と献血の数の増加は、肝炎診断検査市場の成長を促進する上で重要な役割を果たしています。輸血と献血は、個人が進んで血液を提供し、採取、厳格な検査を受け、その後、さまざまな病状、手術、事故、または病気のために追加の血液成分を必要とする患者に投与する、複雑に絡み合ったプロセスです。レシピエントの安全を確保するために、肝炎診断検査を利用して献血された血液を徹底的にスクリーニングし、輸血による肝炎感染のリスクを軽減します。たとえば、2021年12月のNHS血液と移植（NHSBT）のデータは、英国における全血献血量が、2020年の93万3,705人の献血者による1,649,057回と比較して、2021年には96万3,145人の献血者による1,719,630回に増加したことを示しています。この献血量の増加は、全血献血の増加を意味します。献血された血液の安全性と品質を維持するために肝炎診断検査が必要であり、その後肝炎診断検査市場を牽引します。

世界の肝炎症例の急増も、肝炎診断検査市場の成長を推進するもう1つの重要な要因です。肝臓の炎症を特徴とする肝炎は、重大な健康リスクをもたらし、さまざまな症状や合併症を引き起こす可能性があります。肝炎の正確な診断検査は、肝炎感染の存在を特定して確認する上で非常に重要であり、タイムリーな介入と効果的な疾患管理を可能にします。たとえば、2023年のB型肝炎財団によると、年間150万人が肝炎感染症に罹患していると推定されており、これらの疾患によってもたらされる永続的な課題が浮き彫りになっています。肝炎の発生率の増加は、早期発見と管理における信頼性の高い診断検査の重要性を強調しており、それによって市場での肝炎診断検査の需要が高まっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の肝炎診断検査市場、検査タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 血液検査
  • 画像検査
  • 肝生検
  • 世界の肝炎診断検査市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 酵素免疫測定法（ELISA）
  • 迅速診断テスト（RDT）
  • ポリメラーゼ連鎖反応（PCR）
  • 等温核酸増幅検査（INAAT）
  • その他の技術
  • 世界の肝炎診断検査市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 診断研究所
  • 血液バンク
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の肝炎診断検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の肝炎診断検査市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 肝炎診断検査市場の競合情勢
  • 肝炎診断検査市場の企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG
    • Roche Diagnostics

第31章 その他の大手および革新的な企業

  • Quest Diagnostics Incorporated
  • Grifols SA
  • Hologic Inc.
  • BioMerieux SA
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • SD Biosensor Co. Ltd.
  • QIAGEN NV
  • DiaSorin SpA
  • Randox Laboratories Ltd.
  • Luminex Corporation
  • Fujirebio Diagnostics Inc.
  • Trivitron Healthcare Private Limited
  • Trinity Biotech plc
  • MP Biomedicals LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13366

Hepatitis diagnostic tests are medical procedures and laboratory analyses designed to identify and diagnose infections caused by hepatitis viruses, including hepatitis A, B, C, D, and E. These tests are essential for detecting the presence of hepatitis viruses or specific antibodies in a patient's blood or other bodily fluids. The primary goal is to confirm the infection, determine its type, assess severity, and monitor its progression.

The main categories of hepatitis diagnostic tests include blood tests, imaging tests, and liver biopsy. Blood tests involve examining blood samples to assess various constituents such as blood cells, proteins, enzymes, hormones, antibodies, and other chemicals. Various technologies are utilized in these tests, including enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests, polymerase chain reaction (PCR), isothermal nucleic acid amplification tests, and others. These diagnostic tools find applications in diverse healthcare settings such as hospitals, diagnostic laboratories, blood banks, and other medical facilities.

The hepatitis diagnostic tests market research report is one of a series of new reports from The Business Research Company that provides hepatitis diagnostic tests market statistics, including hepatitis diagnostic tests industry global market size, regional shares, competitors with a hepatitis diagnostic tests market share, detailed hepatitis diagnostic tests market segments, market trends, and opportunities, and any further data you may need to thrive in the hepatitis diagnostic test industry. This hepatitis diagnostic tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hepatitis diagnostic tests market size has grown strongly in recent years. It will grow from $4.35 billion in 2023 to $4.64 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth observed during the historic period in the field of hepatitis diagnostic tests can be attributed to several key factors. These include the globalization of healthcare, government initiatives aimed at improving diagnostic capabilities, the high disease burden associated with hepatitis infections, heightened measures for blood safety, and public health campaigns focused on raising awareness and encouraging testing. These factors collectively contributed to the expansion and adoption of hepatitis diagnostic tests during the historical period.

The hepatitis diagnostic tests market size is expected to see strong growth in the next few years. It will grow to $5.85 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth in the forecast period for hepatitis diagnostic tests can be attributed to several key drivers. These include heightened concerns about global health security, population growth and urbanization trends, the implementation of tailored testing strategies, a strong emphasis on elimination programs for hepatitis, and the overall increase in healthcare spending worldwide. Major trends expected in the forecast period include advancements in testing technologies, particularly in the field of molecular diagnostics, the development of multiplex testing for different hepatitis viruses, integration of digital health solutions for improved diagnostics and monitoring, and an increase in strategic collaborations and partnerships within the healthcare sector. These trends collectively contribute to the projected growth and evolution of hepatitis diagnostic testing in the coming period.

The rising number of blood transfusions and blood donations plays a crucial role in driving the growth of the hepatitis diagnostic test market. Blood transfusions and donations are intertwined processes where individuals willingly contribute blood that undergoes collection, rigorous testing, and subsequent administration to patients who require additional blood components due to various medical conditions, surgeries, accidents, or illnesses. To ensure the safety of recipients, hepatitis diagnostic tests are utilized to thoroughly screen donated blood, thereby reducing the risk of transmitting hepatitis through transfusions. For example, data from NHS Blood and Transplant (NHSBT) in December 2021 indicated an increase in whole blood donations in the UK to 1,719,630 by 963,145 donors in 2021, compared to 1,649,057 by 933,705 donors in 2020. This rise in blood donations signifies an increased need for hepatitis diagnostic tests to maintain the safety and quality of donated blood, subsequently driving the hepatitis diagnostic test market.

The surge in hepatitis cases globally is another key factor propelling the growth of the hepatitis diagnostic tests market. Hepatitis, characterized by liver inflammation, poses significant health risks and can lead to various symptoms and complications. Accurate diagnostic tests for hepatitis are crucial in identifying and confirming the presence of hepatitis infections, enabling timely interventions and effective disease management. For instance, according to the Hepatitis B Foundation in 2023, an estimated 1.5 million people contract hepatitis infections annually, highlighting the persistent challenge posed by these diseases. The growing incidence of hepatitis underlines the critical importance of reliable diagnostic tests in early detection and management, thereby fueling the demand for hepatitis diagnostic tests in the market.

The projected impediment to the growth of the hepatitis diagnostic test market stems from the high cost associated with these tests. The considerable expenses related to hepatitis diagnostic procedures are a significant concern for both individuals and healthcare systems. This financial burden could lead to delayed diagnoses, insufficient monitoring, and escalated healthcare expenditures over time. As indicated by a report in April 2023 from the Lancet, the costs attributed to Hepatitis Diagnostic tests range from $890 to $1406, marking an increase of up to 35% compared to standard care treatments. Consequently, the exorbitant cost of these diagnostic tests stands as a hindrance to the market's expansion.

Dominant players in the hepatitis diagnostic test market are concentrating on innovating automated immunoassays, exemplified by the Elecsys HCV Duo, to enhance customer service reliability. Automated immunoassays represent laboratory techniques utilizing automated systems and specialized instruments to conduct various phases of the immunoassay process, encompassing sample handling, reagent mixing, incubation, detection, and result calculation. For instance, in July 2023, Roche Diagnostics India, a biotechnology research company based in India, introduced Elecsys HCV Duo. This advanced solution represents India's maiden fully automated immunoassay available commercially, facilitating the simultaneous and independent evaluation of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. Moreover, this approach streamlines the diagnostic procedure, enabling single-specimen testing and potentially reducing the number of necessary follow-up visits, consequently alleviating the burden on healthcare systems.

In August 2021, BioCheck Inc., a US-based company specializing in diagnostic products, completed the acquisition of DRG International Inc. The exact amount of the acquisition remains undisclosed. This strategic move by BioCheck aims to expedite the accessibility of enhanced and dependable advanced clinical and research diagnostic tests designed for various diseases. DRG International Inc., another US-based entity acquired by BioCheck, is recognized for its repertoire of diagnostic tests, notably including those for hepatitis diagnostics.

Major companies operating in the hepatitis diagnostic tests market report are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

North America was the largest region in the hepatitis diagnostic tests market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hepatitis diagnostic tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hepatitis diagnostic test market consists of revenues earned by entities by providing diagnostic services such as liver ultrasound, computerized tomography (CT) scans, and antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis diagnostic test market also includes sales of laboratory equipment, reagents, and assay components that are used in providing hepatitis diagnostic test services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hepatitis Diagnostic Tests Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hepatitis diagnostic tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hepatitis diagnostic tests? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hepatitis diagnostic tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Test Type: Blood Tests; Imaging Tests; Liver Biopsy
  • 2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Diagnostic Tests (RDTs); Polymerase Chain Reaction (PCR); Isothermal Nucleic Acid Amplification Test (INAAT); Other Technologies
  • 3) By End User: Hospitals; Diagnostic Laboratories; Blood Bank; Other End Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Roche Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hepatitis Diagnostic Tests Market Characteristics

3. Hepatitis Diagnostic Tests Market Trends And Strategies

4. Hepatitis Diagnostic Tests Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Hepatitis Diagnostic Tests Market Size and Growth

  • 5.1. Global Hepatitis Diagnostic Tests Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hepatitis Diagnostic Tests Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hepatitis Diagnostic Tests Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hepatitis Diagnostic Tests Market Segmentation

  • 6.1. Global Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood Tests
  • Imaging Tests
  • Liver Biopsy
  • 6.2. Global Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Rapid Diagnostic Tests (RDTs)
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Test (INAAT)
  • Other Technologies
  • 6.3. Global Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Blood Bank
  • Other End Users

7. Hepatitis Diagnostic Tests Market Regional And Country Analysis

  • 7.1. Global Hepatitis Diagnostic Tests Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hepatitis Diagnostic Tests Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hepatitis Diagnostic Tests Market

  • 8.1. Asia-Pacific Hepatitis Diagnostic Tests Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hepatitis Diagnostic Tests Market

  • 9.1. China Hepatitis Diagnostic Tests Market Overview
  • 9.2. China Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hepatitis Diagnostic Tests Market

  • 10.1. India Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hepatitis Diagnostic Tests Market

  • 11.1. Japan Hepatitis Diagnostic Tests Market Overview
  • 11.2. Japan Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hepatitis Diagnostic Tests Market

  • 12.1. Australia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hepatitis Diagnostic Tests Market

  • 13.1. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hepatitis Diagnostic Tests Market

  • 14.1. South Korea Hepatitis Diagnostic Tests Market Overview
  • 14.2. South Korea Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hepatitis Diagnostic Tests Market

  • 15.1. Western Europe Hepatitis Diagnostic Tests Market Overview
  • 15.2. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hepatitis Diagnostic Tests Market

  • 16.1. UK Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hepatitis Diagnostic Tests Market

  • 17.1. Germany Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hepatitis Diagnostic Tests Market

  • 18.5. France Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hepatitis Diagnostic Tests Market

  • 19.9. Italy Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hepatitis Diagnostic Tests Market

  • 20.13. Spain Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hepatitis Diagnostic Tests Market

  • 21.1. Eastern Europe Hepatitis Diagnostic Tests Market Overview
  • 21.2. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hepatitis Diagnostic Tests Market

  • 22.1. Russia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hepatitis Diagnostic Tests Market

  • 23.1. North America Hepatitis Diagnostic Tests Market Overview
  • 23.2. North America Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hepatitis Diagnostic Tests Market

  • 24.1. USA Hepatitis Diagnostic Tests Market Overview
  • 24.2. USA Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hepatitis Diagnostic Tests Market

  • 25.1. Canada Hepatitis Diagnostic Tests Market Overview
  • 25.2. Canada Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hepatitis Diagnostic Tests Market

  • 26.1. South America Hepatitis Diagnostic Tests Market Overview
  • 26.2. South America Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hepatitis Diagnostic Tests Market

  • 27.1. Brazil Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hepatitis Diagnostic Tests Market

  • 28.1. Middle East Hepatitis Diagnostic Tests Market Overview
  • 28.2. Middle East Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hepatitis Diagnostic Tests Market

  • 29.1. Africa Hepatitis Diagnostic Tests Market Overview
  • 29.2. Africa Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hepatitis Diagnostic Tests Market Competitive Landscape And Company Profiles

  • 30.1. Hepatitis Diagnostic Tests Market Competitive Landscape
  • 30.2. Hepatitis Diagnostic Tests Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danaher Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Roche Diagnostics
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Hepatitis Diagnostic Tests Market Other Major And Innovative Companies

  • 31.1. Quest Diagnostics Incorporated
  • 31.2. Grifols S.A
  • 31.3. Hologic Inc.
  • 31.4. BioMerieux SA
  • 31.5. Beckman Coulter Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. SD Biosensor Co. Ltd.
  • 31.8. QIAGEN N.V.
  • 31.9. DiaSorin S.p.A.
  • 31.10. Randox Laboratories Ltd.
  • 31.11. Luminex Corporation
  • 31.12. Fujirebio Diagnostics Inc.
  • 31.13. Trivitron Healthcare Private Limited
  • 31.14. Trinity Biotech plc
  • 31.15. MP Biomedicals LLC

32. Global Hepatitis Diagnostic Tests Market Competitive Benchmarking

33. Global Hepatitis Diagnostic Tests Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hepatitis Diagnostic Tests Market

35. Hepatitis Diagnostic Tests Market Future Outlook and Potential Analysis

  • 35.1 Hepatitis Diagnostic Tests Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Hepatitis Diagnostic Tests Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Hepatitis Diagnostic Tests Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer